tailieunhanh - Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides

CRISPR-Cas9 has been developed as a therapeutic agent for various infectious and genetic diseases. In many clinically relevant applications, constitutively active CRISPR-Cas9 is delivered into human cells without a temporal control system. Excessive and prolonged expression of CRISPR-Cas9 can lead to elevated off-target cleavage. |

TỪ KHÓA LIÊN QUAN